Next Article in Journal
Antibiotic Discovery: Where Have We Come from, Where Do We Go?
Next Article in Special Issue
A Pilot Study of the Synergy between Two Antimicrobial Peptides and Two Common Antibiotics
Previous Article in Journal / Special Issue
Drug Susceptibility Testing and Synergistic Antibacterial Activity of Curcumin with Antibiotics against Enterotoxigenic Escherichia coli
Open AccessReview

Short Cationic Peptidomimetic Antimicrobials

1
School of Chemistry, University of New South Wales, Sydney, NSW 2052, Australia
2
School of Optometry and Vision Science, University of New South Wales, Sydney, NSW 2052, Australia
*
Author to whom correspondence should be addressed.
Antibiotics 2019, 8(2), 44; https://doi.org/10.3390/antibiotics8020044
Received: 29 March 2019 / Revised: 15 April 2019 / Accepted: 15 April 2019 / Published: 18 April 2019
The rapid growth of antimicrobial resistance against several frontline antibiotics has encouraged scientists worldwide to develop new alternatives with unique mechanisms of action. Antimicrobial peptides (AMPs) have attracted considerable interest due to their rapid killing and broad-spectrum activity. Peptidomimetics overcome some of the obstacles of AMPs such as high cost of synthesis, short half-life in vivo due to their susceptibility to proteolytic degradation, and issues with toxicity. This review will examine the development of short cationic peptidomimetics as antimicrobials. View Full-Text
Keywords: peptidomimetics; antibacterials; cationic groups peptidomimetics; antibacterials; cationic groups
Show Figures

Figure 1

MDPI and ACS Style

Kuppusamy, R.; Willcox, M.; Black, D.S.; Kumar, N. Short Cationic Peptidomimetic Antimicrobials. Antibiotics 2019, 8, 44.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map

1
Back to TopTop